Antibody-linked cytotoxic agents in the treatment of cancer: current status and future prospects.
about
Monoclonal antibodies in clinical medicine.Quantitative analysis of melanoma-associated antigen p97 in normal and neoplastic tissues.Site-specific covalent modification of monoclonal antibodies: in vitro and in vivo evaluations.Antigenicity and drug susceptibility of human osteogenic sarcoma cells "escaping" a cytotoxic methotrexate-albumin-monoclonal antibody conjugateLocalisation and toxicity study of a vindesine-anti-CEA conjugate in patients with advanced cancer.A covalent linkage between daunorubicin and proteins that is stable in serum and reversible by lysosomal hydrolases, as required for a lysosomotropic drug-carrier conjugate: in vitro and in vivo studies.In vivo therapy of a murine B cell tumor (BCL1) using antibody-ricin A chain immunotoxins.Induction of immune cytolysis: tumor-cell killing by complement is initiated by covalent complex of monoclonal antibody and stable C3/C5 convertase.Selective killing of normal or neoplastic B cells by antibodies coupled to the A chain of ricin.Use of antibodies and immunoconjugates for the therapy of more accessible cancers.A vindesine-anti-CEA conjugate cytotoxic for human cancer cells in vitro.The effect of an anti-membrane antibody-methotrexate conjugate on the human prostatic tumour line PC3.Comparative pharmacokinetic properties of murine monoclonal antibody A7 modified with neocarzinostatin, dextran and polyethylene glycol.
P2860
Q34487904-553FF27B-FD61-41A6-8160-A87BDBDEA8FFQ35312046-B816653E-35D6-4258-8519-099EBCB54F6DQ35600422-374DF39B-09F0-4375-92BC-A6CF82D844C4Q35991397-1A6FEF21-0640-44A4-A2E7-268B82D31814Q36047395-81E59B58-3C6D-4C7A-B1F1-B41013F6EF02Q36278838-6371EA25-E59A-441C-90FB-433F93F9C0F9Q36346564-828314C9-03D2-4FDF-B9E5-9CD99B0B180FQ36384230-180078E3-3E47-406D-A251-20417C2DBCA1Q36406768-75A1EB21-4FC9-4C95-99EF-45A6D66F126BQ37174938-FFB852F6-0A95-41BC-BACB-D9168351B76EQ41490919-FB8A431F-73A6-4088-98A9-2B207694AA5CQ41735021-B30B795D-C72B-418E-AA30-1A16F931479EQ55266469-C2F08573-A122-45E3-AEBA-A6490276B514
P2860
Antibody-linked cytotoxic agents in the treatment of cancer: current status and future prospects.
description
1978 nî lūn-bûn
@nan
1978年の論文
@ja
1978年論文
@yue
1978年論文
@zh-hant
1978年論文
@zh-hk
1978年論文
@zh-mo
1978年論文
@zh-tw
1978年论文
@wuu
1978年论文
@zh
1978年论文
@zh-cn
name
Antibody-linked cytotoxic agen ...... t status and future prospects.
@en
Antibody-linked cytotoxic agen ...... t status and future prospects.
@nl
type
label
Antibody-linked cytotoxic agen ...... t status and future prospects.
@en
Antibody-linked cytotoxic agen ...... t status and future prospects.
@nl
prefLabel
Antibody-linked cytotoxic agen ...... t status and future prospects.
@en
Antibody-linked cytotoxic agen ...... t status and future prospects.
@nl
P1476
Antibody-linked cytotoxic agen ...... t status and future prospects.
@en
P2093
P304
P407
P577
1978-09-01T00:00:00Z